nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A therapeutic withdrawal can make a strategic advance
|
Jordon, V.C. |
|
1992 |
3 |
8 |
p. 587-588 |
artikel |
2 |
Awards, appointments
|
|
|
1992 |
3 |
8 |
p. 583-584 |
artikel |
3 |
Book review
|
Bernier, J. |
|
1992 |
3 |
8 |
p. 638-638 |
artikel |
4 |
Book review
|
Hansen, H. H. |
|
1992 |
3 |
8 |
p. 644-644 |
artikel |
5 |
Book review
|
Sessa, C. |
|
1992 |
3 |
8 |
p. 629-629 |
artikel |
6 |
Classified advertisements from ESMO-members and meeting announcements
|
|
|
1992 |
3 |
8 |
p. 604-604 |
artikel |
7 |
Contents of the next issue
|
|
|
1992 |
3 |
8 |
p. 579-579 |
artikel |
8 |
Editorial: Antiosteolytic agents in the management of hypercalcemia
|
Bonjour, Jean-Philippe |
|
1992 |
3 |
8 |
p. 595-595 |
artikel |
9 |
Editorial: A therapeutic withdrawal can make a strategic advance
|
Jordan, V. C. |
|
1992 |
3 |
8 |
p. 595-595 |
artikel |
10 |
Editorial: Infusional anthracyclines: Is slower better? If so, why?
|
Workman, P. |
|
1992 |
3 |
8 |
p. 595-595 |
artikel |
11 |
ESO: A decade of cancer education and training in Europe
|
|
|
1992 |
3 |
8 |
p. 581-582 |
artikel |
12 |
First ESMO course: A good beginning
|
|
|
1992 |
3 |
8 |
p. 584-584 |
artikel |
13 |
Interferon alpha-2-beta enhances immunoscintigraphic localization of monoclonal antibody in malignant melanoma
|
Marroni, B. J. |
|
1992 |
3 |
8 |
p. 664-664 |
artikel |
14 |
In this issue
|
|
|
1992 |
3 |
8 |
p. 579-579 |
artikel |
15 |
J.B. Lippincott Company
|
|
|
1992 |
3 |
8 |
p. 667-667 |
artikel |
16 |
Mechanisms of hypercalcemia in lymphomas
|
Seymour, J. |
|
1992 |
3 |
8 |
p. 664-665 |
artikel |
17 |
MRS as an early indicator of tumour response
|
|
|
1992 |
3 |
8 |
p. 580-581 |
artikel |
18 |
News: AIDS and cancer: Let's begin thinking globally
|
|
|
1992 |
3 |
8 |
p. 580-580 |
artikel |
19 |
Original article: Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: Clinical results and analysis of prognostic factors
|
Pichert, G. |
|
1992 |
3 |
8 |
p. 645-649 |
artikel |
20 |
Original article: Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen
|
Dumontet, C. |
|
1992 |
3 |
8 |
p. 639-644 |
artikel |
21 |
Original article: Pharmacokinetics and metabolism of epirubicin administered as i.v. bolus and 48-h infusion in patients with advanced soft-tissue sarcoma
|
Robert, J. |
|
1992 |
3 |
8 |
p. 651-656 |
artikel |
22 |
Original article: Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: A prospective randomized crossover trial
|
Thürlimann, B. |
|
1992 |
3 |
8 |
p. 619-623 |
artikel |
23 |
Original article: Response after withdrawal of tamoxifen and progestogens in advanced breast cancer
|
Howell, A. |
|
1992 |
3 |
8 |
p. 611-617 |
artikel |
24 |
Original article: Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site
|
Pavlidis, N. |
|
1992 |
3 |
8 |
p. 631-634 |
artikel |
25 |
Original article: The role of age at menarche and at menopause on breast cancer risk: Combined evidence from four case-control studies
|
La Vecchia, C. |
|
1992 |
3 |
8 |
p. 625-629 |
artikel |
26 |
Original article: Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: A randomized trial
|
Janson, F. Tiensuu |
|
1992 |
3 |
8 |
p. 635-638 |
artikel |
27 |
Perhaps not everyone knows that…
|
|
|
1992 |
3 |
8 |
p. 584-585 |
artikel |
28 |
Radon levels too high in Swiss and British studies
|
|
|
1992 |
3 |
8 |
p. 582-582 |
artikel |
29 |
Review: Allergic reactions to cytotoxic drugs - an update
|
O'Brien, M. E. R. |
|
1992 |
3 |
8 |
p. 605-610 |
artikel |
30 |
Rio: Just an occasion to go swimming?
|
|
|
1992 |
3 |
8 |
p. 582-582 |
artikel |
31 |
Short report: Bi-weekly 2-day schedule of high-dose folinic acid, 5-fluorouracil bolus and infusion in pretreated advanced epithelial ovarian cancer: A phase II study
|
Louvet, C. |
|
1992 |
3 |
8 |
p. 657-658 |
artikel |
32 |
Short report: Multicenter phase II trial of brequinar sodium in patients with advanced melanoma
|
Natale, R. |
|
1992 |
3 |
8 |
p. 659-660 |
artikel |
33 |
Short report: Treatment of resistant tumor-induced hypercalcemia with escalating doses of pamidronate (APD)
|
Pecherstorfer, M. |
|
1992 |
3 |
8 |
p. 661-663 |
artikel |
34 |
Special article: The epidemiology of acquired immunodeficiency syndrome and associated tumours in Europe
|
Serraino, D. |
|
1992 |
3 |
8 |
p. 595-603 |
artikel |
35 |
Supportive Care in Cancer
|
|
|
1992 |
3 |
8 |
p. 668-668 |
artikel |
36 |
The above letter was referred to the author, who responds as follows:
|
Dodwell, D. J. |
|
1992 |
3 |
8 |
p. 665-665 |
artikel |
37 |
The American Congress questions meta-analysis
|
|
|
1992 |
3 |
8 |
p. 582-582 |
artikel |
38 |
The University of Berne, Switzerland (Faculty of Medicine/Inselspital)
|
|
|
1992 |
3 |
8 |
p. 663-663 |
artikel |
39 |
To fight AIDS, the Swiss Government ready to provide heroin
|
|
|
1992 |
3 |
8 |
p. 583-583 |
artikel |